"From our nationally renowned oncologists to some of the field's leading research scientists, patients at West Cancer Center & Research Institute are surrounded by a team of cancer experts and incredible support services throughout their cancer journey and beyond."

During the past decade, West Cancer Center conducted 61 clinical trials. In the 10-year time frame, 61 clinical trials started and 25 clinical trials were completed, i.e. on average, 41% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 20 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "West Cancer Center" #1 sponsor was "Hoffmann-La Roche" with 15 trials, followed by "Bristol-Myers Squibb" with 6 trials sponsored, "Alliance for Clinical Trials in Oncology" with 4 trials sponsored, "National Cancer Institute (NCI)" with 4 trials sponsored and "SWOG Cancer Research Network" with 4 trials sponsored. Other sponsors include 34 different institutions and companies that sponsored additional 33 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "West Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 10 trials as a collaborator, "Merck Sharp & Dohme LLC" with 3 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "NRG Oncology" with 2 trials as a collaborator and "United States Department of Defense" with 2 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "West Cancer Center" are "Breast Cancer" (12 trials), "Cancer" (3 trials), "Lymphoma" (3 trials), "Melanoma" (3 trials) and "Renal Cell Carcinoma (RCC)" (3 trials). Many other conditions were trialed in "West Cancer Center" in a lesser frequency.

Most popular intervention types in "West Cancer Center" are "Drug" (54 trials), "Other" (11 trials), "Biological" (7 trials), "Radiation" (6 trials) and "Device" (4 trials). Other intervention types were less common.

The name of intervention was led by "Nivolumab" (10 trials), "Atezolizumab" (8 trials), "Pembrolizumab" (8 trials), "Paclitaxel" (6 trials) and "Carboplatin" (5 trials). Other intervention names were less common.

The vast majority of trials in "West Cancer Center" are 62 trials for "All" genders, 7 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "West Cancer Center". 1 are not yet recruiting, 11 are recruiting, 21 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 27 completed trials in West Cancer Center, 1 suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in West Cancer Center, 17 "Phase 1" clinical trials were conducted, 30 "Phase 2" clinical trials and 28 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".